384 related articles for article (PubMed ID: 28882703)
1. PEGylation for enhancing nanoparticle diffusion in mucus.
Huckaby JT; Lai SK
Adv Drug Deliv Rev; 2018 Jan; 124():125-139. PubMed ID: 28882703
[TBL] [Abstract][Full Text] [Related]
2. Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus.
Xu Q; Boylan NJ; Cai S; Miao B; Patel H; Hanes J
J Control Release; 2013 Sep; 170(2):279-86. PubMed ID: 23751567
[TBL] [Abstract][Full Text] [Related]
3. Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.
Xu Q; Ensign LM; Boylan NJ; Schön A; Gong X; Yang JC; Lamb NW; Cai S; Yu T; Freire E; Hanes J
ACS Nano; 2015 Sep; 9(9):9217-27. PubMed ID: 26301576
[TBL] [Abstract][Full Text] [Related]
4. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.
Tang BC; Dawson M; Lai SK; Wang YY; Suk JS; Yang M; Zeitlin P; Boyle MP; Fu J; Hanes J
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19268-73. PubMed ID: 19901335
[TBL] [Abstract][Full Text] [Related]
6. Beyond PEGylation: Alternative surface-modification of nanoparticles with mucus-inert biomaterials.
Khutoryanskiy VV
Adv Drug Deliv Rev; 2018 Jan; 124():140-149. PubMed ID: 28736302
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol.
Yang M; Lai SK; Yu T; Wang YY; Happe C; Zhong W; Zhang M; Anonuevo A; Fridley C; Hung A; Fu J; Hanes J
J Control Release; 2014 Oct; 192():202-8. PubMed ID: 25090196
[TBL] [Abstract][Full Text] [Related]
8. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.
Lai SK; Suk JS; Pace A; Wang YY; Yang M; Mert O; Chen J; Kim J; Hanes J
Biomaterials; 2011 Sep; 32(26):6285-90. PubMed ID: 21665271
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle diffusion in respiratory mucus from humans without lung disease.
Schuster BS; Suk JS; Woodworth GF; Hanes J
Biomaterials; 2013 Apr; 34(13):3439-46. PubMed ID: 23384790
[TBL] [Abstract][Full Text] [Related]
10. Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.
Suk JS; Kim AJ; Trehan K; Schneider CS; Cebotaru L; Woodward OM; Boylan NJ; Boyle MP; Lai SK; Guggino WB; Hanes J
J Control Release; 2014 Mar; 178():8-17. PubMed ID: 24440664
[TBL] [Abstract][Full Text] [Related]
11. Mucus-Penetrating Particles and the Role of Ocular Mucus as a Barrier to Micro- and Nanosuspensions.
Popov A
J Ocul Pharmacol Ther; 2020; 36(6):366-375. PubMed ID: 32667250
[TBL] [Abstract][Full Text] [Related]
12. Technological strategies to estimate and control diffusive passage times through the mucus barrier in mucosal drug delivery.
Newby JM; Seim I; Lysy M; Ling Y; Huckaby J; Lai SK; Forest MG
Adv Drug Deliv Rev; 2018 Jan; 124():64-81. PubMed ID: 29246855
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo.
Maisel K; Reddy M; Xu Q; Chattopadhyay S; Cone R; Ensign LM; Hanes J
Nanomedicine (Lond); 2016 Jun; 11(11):1337-43. PubMed ID: 27171816
[TBL] [Abstract][Full Text] [Related]
14. A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles.
Mert O; Lai SK; Ensign L; Yang M; Wang YY; Wood J; Hanes J
J Control Release; 2012 Feb; 157(3):455-60. PubMed ID: 21911015
[TBL] [Abstract][Full Text] [Related]
15. Coarse-grained modeling and dynamics tracking of nanoparticles diffusion in human gut mucus.
Zhao L; Arias SL; Zipfel W; Brito IL; Yeo J
Int J Biol Macromol; 2024 May; 267(Pt 2):131434. PubMed ID: 38614182
[TBL] [Abstract][Full Text] [Related]
16. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.
Suk JS; Lai SK; Boylan NJ; Dawson MR; Boyle MP; Hanes J
Nanomedicine (Lond); 2011 Feb; 6(2):365-75. PubMed ID: 21385138
[TBL] [Abstract][Full Text] [Related]
17. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.
Lai SK; O'Hanlon DE; Harrold S; Man ST; Wang YY; Cone R; Hanes J
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1482-7. PubMed ID: 17244708
[TBL] [Abstract][Full Text] [Related]
18. Mucus-Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal Surfaces.
Yu T; Chisholm J; Choi WJ; Anonuevo A; Pulicare S; Zhong W; Chen M; Fridley C; Lai SK; Ensign LM; Suk JS; Hanes J
Adv Healthc Mater; 2016 Nov; 5(21):2745-2750. PubMed ID: 27717163
[TBL] [Abstract][Full Text] [Related]
19. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.
Suk JS; Xu Q; Kim N; Hanes J; Ensign LM
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):28-51. PubMed ID: 26456916
[TBL] [Abstract][Full Text] [Related]
20. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
Lai SK; Wang YY; Hanes J
Adv Drug Deliv Rev; 2009 Feb; 61(2):158-71. PubMed ID: 19133304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
